Search Results - "Geoffrey W. McCaughan"
-
1
Alcoholic Liver Disease in Asia, Europe, and North America
Published in Gastroenterology (New York, N.Y. 1943) (01-06-2016)“…Alcoholic liver diseases comprise a spectrum of clinical disorders and changes in liver tissue that can be detected by pathology analysis. These range from…”
Get full text
Journal Article -
2
COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
Published in Journal of diabetes (01-09-2020)“…The coronavirus disease 2019 (COVID‐19) pandemic is caused by a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), similar to…”
Get full text
Journal Article -
3
Current perspectives on the tumor microenvironment in hepatocellular carcinoma
Published in Hepatology international (01-12-2020)“…Hepatocellular carcinoma (HCC) is a heterogeneous inflammation-driven malignancy, which, despite significant advances in management, continues to portend a…”
Get full text
Journal Article -
4
Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
Published in PloS one (24-05-2016)“…Robust biomarkers for population-level hepatocellular carcinoma (HCC) surveillance are lacking. We compared serum midkine (MDK), dickkopf-1 (DKK1), osteopontin…”
Get full text
Journal Article -
5
Frailty in advanced liver disease
Published in Liver international (01-12-2018)“…Prognostication of patients with cirrhosis is complex, depending on more than just the severity of liver disease. Scores such as the model for end‐stage liver…”
Get full text
Journal Article -
6
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
Published in Therapeutic Advances in Medical Oncology (2019)“…The introduction of immunotherapies has been a major development in the treatment of many advanced cancers, including hepatocellular carcinoma (HCC). We are…”
Get full text
Book Review Journal Article -
7
A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs
Published in Nature communications (10-02-2024)“…While CD4 + T cells are a prerequisite for CD8 + T cell-mediated protection against intracellular hepatotropic pathogens, the mechanisms facilitating the…”
Get full text
Journal Article -
8
Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?
Published in Hepatology (Baltimore, Md.) (01-12-2011)“…Screening for hepatocellular carcinoma (HCC) is commonly practiced and recommended in published guidelines, but evidence for its efficacy has been…”
Get full text
Journal Article -
9
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Published in Hepatology international (01-11-2019)“…In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained virological response (SVR) is very high, but close attention must be…”
Get full text
Journal Article -
10
Induction Phase of Spontaneous Liver Transplant Tolerance
Published in Frontiers in immunology (11-09-2020)“…The liver has long been known to possess tolerogenic properties. Early experiments in liver transplantation demonstrated that in animal models, hepatic…”
Get full text
Journal Article -
11
Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling
Published in The Journal of clinical investigation (01-08-2020)“…Ligand-dependent activation of Hedgehog (Hh) signaling in cancer occurs without mutations in canonical pathway genes. Consequently, the genetic basis of Hh…”
Get full text
Journal Article -
12
The liver contains distinct interconnected networks of CX3CR1+ macrophages, XCR1+ type 1 and CD301a+ type 2 conventional dendritic cells embedded within portal tracts
Published in Immunology and cell biology (01-07-2022)“…Portal tracts are key intrahepatic structures where leukocytes accumulate during immune responses. They contain the blood inflow, which includes portal blood…”
Get full text
Journal Article -
13
Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses
Published in Proceedings of the National Academy of Sciences - PNAS (24-06-2014)“…CD8 T-cell responses to liver-expressed antigens range from deletional tolerance to full effector differentiation resulting in overt hepatotoxicity. The…”
Get full text
Journal Article -
14
Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation
Published in Nature communications (14-03-2024)“…Developing clinically predictive model systems for evaluating gene transfer and gene editing technologies has become increasingly important in the era of…”
Get full text
Journal Article -
15
Hepatocyte entry leads to degradation of autoreactive CD8 T cells
Published in Proceedings of the National Academy of Sciences - PNAS (04-10-2011)“…Although most self-reactive T cells are eliminated in the thymus, mechanisms to inactivate or control T cells specific for extrathymic antigens are required…”
Get full text
Journal Article -
16
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate
Published in Frontiers in immunology (18-09-2023)“…Introduction Liver cancers exhibit abnormal (leaky) vasculature, hypoxia and an immunosuppressive microenvironment. Normalization of tumor vasculature is an…”
Get full text
Journal Article -
17
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
Published in Clinical chemistry (Baltimore, Md.) (01-10-2005)“…Staging hepatic fibrosis by liver biopsy guides prognosis and treatment of hepatitis C, but is invasive and expensive. We sought to create an algorithm of…”
Get full text
Journal Article -
18
Lamivudine Plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation
Published in Gastroenterology (New York, N.Y. 1943) (01-03-2007)“…Background & Aims: High-dose intravenous hepatitis B immunoglobulin (HBIG) may prevent recurrent hepatitis B virus (HBV) infection, but the cost has limited…”
Get full text
Journal Article -
19
dipeptidyl peptidase IV family in cancer and cell biology
Published in The FEBS journal (01-03-2010)“…Of the 600+ known proteases identified to date in mammals, a significant percentage is involved or implicated in pathogenic and cancer processes. The…”
Get full text
Journal Article -
20
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen–positive liver transplant candidates
Published in Liver transplantation (01-03-2013)“…Without effective prophylaxis, liver transplantation for hepatitis B virus (HBV)–related liver disease is frequently complicated by severe and rapidly…”
Get full text
Journal Article